Test Price
2,800 AED✅ Home Collection Available
TYRP1 Oculocutaneous Albinism Type 3 (OCA3) Genetic Test in UAE | AED 2800 | DHA Licensed
Executive Summary & Core Metrics
Clinical Excellence & Patient Convenience
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified Processing.
- Premium Logistics: Hospital-Grade Home Collection with ISO-Certified Cold‑Chain transport, VIP Mobile Phlebotomy (paid).
- Clinical Guidance: Post‑test telephonic clinical guidance for result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731
Test Overview & Methodology
This Next‑Generation Sequencing (NGS) test analyses the entire coding region of the TYRP1 gene to detect pathogenic variants causing oculocutaneous albinism type 3 (OCA3), an autosomal recessive disorder characterised by reduced pigmentation of skin, hair, and eyes with associated visual impairments.
| Feature | Our NGS OCA3 Test | Closest Alternative (Single‑Gene Sanger) |
|---|---|---|
| Methodology | Next‑Generation Sequencing (NGS) – full gene coverage | Sanger sequencing of selected exons only |
| Turnaround Time | 3 – 4 weeks | 6 – 8 weeks |
| Price (AED) | 2800 | 3500+ |
| Included Genetic Counselling | Pre‑ & post‑test session (pedigree, clinical correlation) | Often not included |
| UAE Regulatory Alignment | Full DHA/MOHAP, PDPL & Health Data Protection compliance | May lack local legal safeguarding |
Physician Insight & Safety Protocols
As a Consultant Medical Genetics, I understand the profound implications of a genetic diagnosis of oculocutaneous albinism. This NGS test provides the molecular precision needed to confirm OCA3, enabling tailored counselling on sun protection, visual aids, and lifelong surveillance. Every result must be correlated with the full clinical phenotype and family history. I encourage patients to engage in open dialogue with their genetic counsellor and ophthalmologist.
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Safety Advisory
Safety Exclusion Criteria & Emergency Red Flags
- Exclusion: Active severe infection, bleeding disorder, or inability to provide informed consent (guardian required for minors).
- Exclusion: Patients under 18 without DHA‑compliant paediatric consent pathway.
- ER Red Flag: Sudden vision loss or severe eye pain – seek immediate ophthalmic emergency care.
- ER Red Flag: Intense photophobia with headache, nausea, or vomiting – possible acute angle closure.
Exclusion Criteria
Contraindications for Home Collection
- Severe bleeding disorder (e.g., haemophilia, anticoagulant therapy).
- Active severe infection at the planned venipuncture site.
- Inability to provide informed consent (minor or adult lacking capacity).
Patient FAQ & Clinical Guidance
1. What is the TYRP1 OCA3 NGS test and who should consider it?
This test sequences the entire TYRP1 gene to confirm a diagnosis of oculocutaneous albinism type 3. It is recommended for individuals presenting with fair skin, light hair, nystagmus, reduced visual acuity, and a family history suggestive of autosomal recessive albinism.
2. How is the test performed and what is the turnaround time?
A standard venous blood sample is collected by a certified phlebotomist at your home or a designated collection centre. The sample is processed using NGS technology, and results are delivered within 3 to 4 weeks.
3. Is this test approved by UAE health authorities and covered by insurance?
Yes, this test is fully compliant with DHA and MOHAP standards. Many insurance plans reimburse genetic testing for albinism; please verify your coverage via WhatsApp at +971 54 548 8731.
4. What results can I expect and how are they interpreted?
Results will indicate whether a pathogenic variant in TYRP1 is identified. A positive result confirms OCA3; a negative result does not exclude all forms of albinism. A genetic counsellor will explain findings and recommend follow‑up care.
UAE Regulatory & Data Privacy Adherence
Data Privacy & Legal Compliance
This test operates in full compliance with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genomic data is encrypted and stored within UAE‑based servers. Clinical safety and patient consent follow the standards of Federal Decree‑Law No. 4 of 2016 on Medical Liability.
Clinical & Logistical Metadata
| Test Name | TYRP1 Oculocutaneous Albinism Type 3 (OCA3) Genetic Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3 – 4 weeks |
| Sample Type / Matrix | Peripheral whole blood (3 – 5 ml in EDTA tube) |
| Methodology Used | Next‑Generation Sequencing (NGS) – full gene coverage |
| ICD‑10‑CM Code | E70.32 |
| LOINC Code | 21636-6 |
| DHA Facility License & Laboratory Address | License No. 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians